Depression is usually associated with alterations in the monoaminergic system. However, new evidences suggest the involvement of the glutamatergic system in the aetiology of depression. Here we explored the glutamatergic system in a rat model of depression (i.e., the flinders sensitive line (FSL)) to reveal the mechanism underlying the emotional and cognitive aspects associated with the disease. We showed a dramatically elevated level of baseline glutamatergic synaptic transmission by whole-cell recordings as well as impairment in longterm potentiation induced by high-frequency stimulation in hippocampal slices from FSL rats compared with Sprague-Dawley rats. At behavioural level, FSL rats displayed recognition memory impairment in the novel object recognition test. Enantioselective chromatography analysis revealed lower levels of D-serine in the hippocampus of FSL rats and both synaptic plasticity and memory impairments were restored by administration of D-serine. We also observed dysfunctional astrocytic glutamate regulation including downregulation of the glia glutamate transporter GLAST as shown by western blot. One possibility is that the dysfunctional astrocytic glutamate reuptake triggers a succession of events, including the reduction of D-serine production as a safety mechanism to avoid NMDA receptor overactivation, which in turn causes the synaptic plasticity and memory impairments observed. These findings open up new brain targets for the development of more potent and efficient antidepressant drugs.
Introduction
Depression is a common, disabling disease with a high cost for society, 1 that is characterised by both emotional and cognitive symptoms. However, the relationship between these two symptoms of depression is poorly understood. The currently used therapies are not suitable for treating all patients, 2 and the episodic deficits in memory and learning that are associated with depression often persist after the emotional symptoms have resolved. [3] [4] [5] These discrepancies may suggest the involvement of different mechanisms in the origin of these two key aspects of depression. 6 On the other hand, clinical studies have indicated that cognition has a role in the regulation of emotions, 7 and the opposite-that is, a cognitive decline can follow emotional symptoms-has also been described. 8 Thus is possible that an unexplored shared mechanism is involved in the aetiology of cognitive and emotional aspects of depression.
Recently, new studies have focused on problems in the brain's glutamatergic system in depression. [9] [10] [11] Clinical studies have reported glutamatergic abnormalities in plasma, serum, cerebrospinal fluid and brain tissue of depressed patients (for review, see Sanacora et al. 12 ) and experimental studies in animal models of depression have suggested the implication of discrete yet potentially interacting mechanisms in the genesis of glutamatergic abnormalities. 13 These mechanisms include neuroplasticity, 14 neurogenesis 15 and dysfunctional astrocytic regulation of glutamate transmission. 16, 17 Interestingly, all of these mechanisms have been associated with memory deficits. 18, 19 However, little is known about how these alterations affect the function of glutamatergic neurocircuits in depression and their exact contribution to the various depressive symptoms. Moreover, although these studies have suggested that the glutamatergic system is altered in several brain regions, a reduction in the size of the hippocampus is one of the most commonly described findings in depressed patients. 20 Given the prominent role that the hippocampus has in memory 21 and its potential role in emotional symptoms, 22 we asked which hippocampal molecular and cellular mechanisms might be implicated in the emotional and cognitive symptoms of depression.
We used the flinders sensitive line (FSL) rat strain, a well-validated animal model of depression. The FSL strain exhibits several depressive-like responses in various behavioural tests, including reduced bar-pressing for reward, increased immobility in the forced swim test and increased freezing in response to shock. Additionally, FSL rats display increased REM sleep, decreased immune response and decreased appetite 23 and more recently, FSL rats were shown to exhibit decreased emotional memory. 24 At hippocampus level these rats present reduced hippocampus volume and lower spine density 25 as well as synaptic plasticity impairments. 26 We investigated the glutamatergic system in the hippocampus of FSL rats using a combination of electrophysiological, molecular and behavioural approaches. Based on our results, we propose a mechanism in which dysfunctional astrocytic regulation of glutamate affects glutamatergic transmission, thereby causing memory deficits that can be restored independently of the emotional aspects of depression.
Materials and methods

Animals and housing
All of the experiments in this study were performed on male Sprague-Dawley (SD) rats (Harlan, Horst, The Netherlands) or male FSL rats that were bred in-house. The animals were housed under standard laboratory conditions. Imported rats were allowed to acclimate to their new environment for a minimum of 6 days (for electrophysiology) and 2-3 weeks (for behavioural) before any experimental manipulation. The experiments were approved by the local animal ethics committees of Stockholm North and Karolinska Institutet in Sweden.
Electrophysiology
Whole-cell recordings. Sixteen to twenty three-dayold SD and FSL rats were anaesthetised with isoflurane, and their brains were removed rapidly into an ice-cold oxygenated (95% O 2 and 5% CO 2 ) highsucrose solution that contained (in mM): 220 sucrose, 2.5 KCl, 1.4 NaH 2 PO 4 , 26 NaHCO 3 , 1 CaCl 2 , 4 MgCl 2 and 10 glucose, pH 7.4 (320-330 mOsm). Horizontal hippocampal slices (350 mm) were prepared, and the slices were incubated for at least 1 h in an interface chamber containing artificial cerebrospinal fluid that consisted of (in mM): 130 NaCl, 3.5 KCl, 1.25 NaH 2 PO 4 , 24 NaHCO 3 , 2 CaCl 2 , 1.3 MgCl 2 and 10 glucose, pH 7.4 (330 mOsm). Whole-cell voltage clamp recordings of CA1 pyramidal cells were made in a submersion chamber with patch electrodes (4-6 MO) filled with a solution containing (in mM): 110 (for excitatory postsynaptic currents (EPSCs)) or 20 (for inhibitory PSCs (IPSCs)) K-gluconate, 10 (EPSCs) or 100 (IPSCs) KCl, 4 Mg 2 -ATP, 10 phosphocreatine, 0.3 Na 2 -GTP and 10 HEPES, pH 7.3 with KOH (270-290 mOsm). The cells were voltage clamped at À65 mV, and either spontaneous EPSCs or IPSCs (sEPSCs or sIPSCs) were recorded using a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA). The data were acquired using pCLAMP 10 (Molecular Devices). Recordings with a membrane potential (Vm) that was more positive than À55 mV and/or has a access resistances (Rs) > 30 MO were excluded, and only those cells in which both the access resistance and Vm were stable (i.e., a change of < 10%) were included in the analysis. All PSCs were analysed using Mini Analysis software (Synaptosoft, Decatur, GA, USA). Detection criteria included IPSCs and EPSCs with an amplitude > 8 pA and a 20-80% decay-rise time > 0. The data are expressed as the percentage of the baseline that was recorded for each cell during the 3 min preceding the application of the drug that was being tested, and the data represent the average of 3 min of recording. Miniature EPSCs were recorded from 7-10 min following the application of 0.5 mM tetrodotoxin to the bath to block action potentials.
The numerical values are expressed as the mean± s.e.m. and n indicates the number of neurons that were tested.
Field recordings. Hippocampal slices (400 mm) were prepared from 6-12-week-old rats as described above, except that the following regular artificial cerebrospinal fluid solution was used during the dissection (in mM): 130 NaCl, 3.5 KCl, 1.25 NaH 2 PO 4 , 24 NaHCO 3 , 2 CaCl 2 , 1 MgCl 2 and 10 glucose, pH 7.4 (330 mOsm). The slices were incubated in an interface chamber for at least 2 h and were then transferred to the recording chamber. For the Schaffer collateral-CA1 recordings, an extracellular recording pipette (filled with regular artificial cerebrospinal fluid) and a bipolar concentric electrode (FHC, Bowdoin, ME, USA) were placed in the stratum radiatum and were separated by a distance of B500 mm. Field excitatory postsynaptic potentials (fEPSP) were evoked by electrical stimulation of Schaffer collateral. NMDA receptor-mediated fEPSP were recorded in slices perfused in a low (0.1 mM) Mg 2 þ artificial cerebrospinal fluid supplemented with the AMPA/kainate receptor antagonist DNQX (10 mM). For the dentate gyrus recordings, the extracellular recording and stimulating electrodes were placed in the middle third of the molecular layer and were separated by B250 mm. Individual synaptic responses were elicited at 10 s intervals, and input-output curves were obtained after the recording was stable. The stimulus intensity was set to B60% of the intensity that triggered population spikes and was determined empirically for each cell. For the dentate gyrus recordings, we only included responses that did not exhibit paired pulse facilitation to ensure that medial perforant path synapses were being examined. 27 For measuring long-term plasticity (LTP) in the CA1 region, stimuli were applied every 60 s for at least 20 min before LTP was induced using three trains of high-frequency stimulation (HFS) (100 pulses at 100 Hz applied at 20 s intervals); in the dentate gyrus, LTP was induced with three runs of HFS that consisted of eight trains of eight pulses at 200 Hz applied at 10-min intervals in the presence of the GABA A receptor antagonist picrotoxin (50 mM). Synaptic strength was monitored for 60 min and calculated using the initial rising slope phase of the fEPSP. The data were normalised with respect to the mean fEPSP slope that was recorded during the last 20 min of the baseline period in control medium.
Behavioural experiments
Object recognition testing. Object recognition testing was performed in a Plexiglas box (length: 80 cm, width: 40 cm, height: 40 cm). The sides of the box contained a pattern to provide local visual cues and the objects were plastic toys. The rats exhibited no bias for any objects or for either side of the test box. The rats were handled for a minimum of 6 days before being subjected to behavioural testing and were habituated to the test box for 20 min on the day before the exploration session. During the exploration session, two random objects were attached to opposite walls of the testing box and the rats were allowed to explore the objects for a maximum of either 5 or 15 min for short-or long-term memory testing, respectively. To correct for the difference in exploration time in SD versus FSL rats, we alternated between SD and FSL rats and the exploration time was monitored on line during the learning session. When a SD rat had reached the same exploration time as the previous FSL rat it was taken out from the box.
A test session of 5 min was performed after a retention interval of either 1 or 24 h. During this test session one of the two objects used in the exploration session was replaced by a replica and a novel object replaced the other. The types of objects and the location of the novel object were randomised between animals.
The behaviour of the subjects in each trial was recorded on video, and the exploration time was scored by an observer blinded to the experimental conditions. Exploration was defined as sniffing, biting, licking or touching the object with the nose. During the test session, a recognition index was calculated using the formula (CÀA)/(C þ A), with C being the time spent exploring the novel object, and A being the time spent exploring the familiar object. Animals were excluded from the study when one of the objects was not explored or when their total object exploration time was shorter than 5 s during either session.
Forced swim test. We used a modified version of the Porsolt forced swim test 28 where animals were tested for 5 min on only 1 day. This modification has previously been described as an adequate test of depression in FSL. 23 The rats were immersed in a glass cylinder (height: 50 cm, diameter: 30 cm) that was filled with water at 25 1C. The water depth was adjusted according to the body weight of each animal. Each trial lasted 5 min. Immobility was defined as no additional movements by the rat beyond those that were required to keep the head above the water.
Drugs and administration
Each of the following drugs was dissolved to its final concentration in physiological saline before application: tetrodotoxin, DL-threo-b-benziloxyaspartic acid (DL-TBOA), 1S,2S,5R,6S-2-aminobicyclo (3.1.0) hexane-2,6-dicarboxylic acid (LY354740), 6,7-dinitroquinoxaline-2,3-dione (DNQX), (2R)-amino-5-phosphonopentanoate (AP-5) (Tocris Bioscience, Bristol, UK), picrotoxin and D-serine (Sigma-Aldrich, St Louis, MO, USA). For the electrophysiology experiments, each drug was applied to the bath; for the behavioural experiments, D-serine and LY354740 was administered subcutaneously at a dosage of 600 mg kg À1 and 1 mg mg À1 , respectively.
Biochemical experiments
The following antibodies were used: GluR1 (Upstate, Temecula, CA, USA), NR1 (SYSY, Göttingen, Germany), NR2A (Tocris Bioscience), GluR2, GFAP, GLAST (human EAAT1) and GLT-1 (human EAAT2) (Abcam, Cambridge, UK). b-actin and a-tubulin (Millipore, Temecula, CA, USA) were used as loading controls.
Western blotting
Rat hippocampi were rapidly dissected and frozen on dry ice before sonication in 1% sodium dodecyl sulphate buffer containing protease inhibitor (Roche Diagnostics, Mannheim, Germany). Equal amounts of protein (30-15 mg) were loaded onto a NUPAGE Novex Bis-Tris Mini Gel and transferred to PVDF membranes. Detection was based on a fluorescent secondary antibody that was visualised using the LICOR (Lincoln, NE, USA) Odyssey infrared fluorescence detection system. The data were quantified using ImageJ software (NIH, Bethesda, MD, USA).
Immunohistochemistry SD and FSL rats were anesthetised and transcardially perfused with 100 ml of 0.1 M. Phosphate-buffered saline (PBS) followed by 300 ml of 10% formaldehyde in 0.1 M PBS. The brains were rapidly dissected, submerged in 10% formaldehyde in 0.1 M PBS overnight at 41C and then cryoprotected for 3 days in 0.1 M PBS containing serial sucrose concentrations of (w/v) 10, 20 and 30%. Serial coronal sections (40 mm) were cut on a freeze microtome (Leitz) and stored at 41C in 0.1 M PBS containing 0.1% sodium azide. For GFAP immunostaining, free-floating sections were incubated for 48 h at 41C in a primary rabbit anti-GFAP antibody, and the secondary antibody, a biotinylated goat anti-rabbit (1:200; Vector Laboratories, Burlingame, CA, USA), was applied. The signal was amplified using an avidin-biotin complex (Vectastain Elite ABC kit; Vector Laboratories) and visualised with diaminobenzidine (Vector laboratories). The analysis was performed using an Axio Imager M1 (Zeiss, Oberkochen, Germany) with a Â 100 objective by an investigator who was blinded to the animal strain. Somas were traced manually in a live image using the Neurolucida Software (MBF, Wilson, VT, USA). Astrocytic somas were identified as the enlarged area in the intersection of at least four branches. The average cell body area for each animal was compared.
Enantioselective liquid chromatography-fluorescence detection for the quantification of D-serine in brain homogenates after derivatisation with o-phthalaldehyde Tissue samples were prepared by sonicating freshfrozen hippocampi in 500 ml of 0.1M NHClO 4 . Each standard/sample was neutralised with an equal amount of 0.1 M NaOH, and 9 ml of the neutralised standard/sample was derivatised using 9 ml of the o-phthalaldehyde/N-isobutyryl-L-cysteine mixture. The enantioselective chromatography experiments were performed using a Shiseido capcell pak MG C 18 column (Analis, Namur, Belgium). The compounds were eluted by gradient elution with a mobile phase that was delivered at a rate of 0.17 ml min
À1
. The gradient elution was performed using mobile phase A (0.025 M phosphate solution, pH 9) and mobile phase B (methanol:water 60:40). For fluorescence detection, an RF-10Axl Shimadzu spectrofluorometric detector was modified by introducing a 2-ml semi-microcell (Shimadzu, Duisburg, Germany). The derivates were measured with excitation and emission wavelengths of 340 and 450 nm, respectively. The integration computer programme Clarity (DataApex, Antec, Zoeterwoude, the Netherlands) was used to integrate the chromatograms. A detailed description of the method is provided as Supplementary Material. All analyses were performed by a scientist blinded to the rat strain.
Statistical analysis
Statistical analysis was performed using the Prism 5 program (GraphPad software, USA). Statistical significance was tested using the non-parametric MannWhitney U test, the unpaired two-tailed Student's t-test or ANOVA, where applicable.
Results
Increased synaptic glutamatergic activity and decreased synaptic plasticity in the hippocampi of FSL rats In order to compare glutamatergic transmission in FSL rats with control (i.e., SD) rats, we used wholecell patch-clamp recordings and measured sEPSC in hippocampal slices from young (P16-P23) SD and FSL rats. The frequency of the sEPSC events in the FSL rats was 7.8 ± 1.6 Hz, which was significantly higher than the frequency in the SD rats (2.3 ± 0.2; P = 0.0002, Mann-Whitney test) (Figures 1a and b) . Strikingly, there was no difference in either the amplitude (Figure 1b) or the kinetics of these events (Supplementary Table 1 ). To assess differences in response to individual synaptic vesicles from single synapses we recorded miniature EPSCs from the same cells in the presence of 0.5 mM tetrodotoxin (Figures 1c and d) . In contrast to the spontaneous activity in the absence of tetrodotoxin, no difference was observed in FSL rats compared with SD rats in neither miniature EPSC frequency nor amplitude (Figure 1d ). In addition we did not observe any significant difference in the protein expression levels of the glutamate receptor subunits NR1, NR2A, GluR1 and GluR2 (Figures 1e  and f) , although a non-significant decreasing trend was observed in the NR1 subunit of the NMDA receptor (P = 0.15, Mann-Whitney test). This trend, however, was not accompanied with changes in evoked NMDA-fEPSP (Supplementary Figure 1a) . Our data thus indicate that the increased sEPSC frequency in FSL rats in not because of changes specifically at excitatory synapses. Instead, it could be caused by decreased inhibition. However, when we recorded sIPSCs we did not observed any difference in frequency or amplitude between FSL rats and SD rats (Supplementary Figure 2) .
To study whether LTP in the hippocampi of FSL rats was also altered, we recorded Schaffer collateralevoked fEPSP in the stratum radiatum of hippocampal slices from adult SD and FSL rats. In SD rats, the application of HFS induced robust LTP (to 198±8% of baseline 40-45 min after induction), whereas in FSL rats the induction and maintenance of LTP were significantly impaired (146±6% after 1-5 min and 121 ± 13% after 40-45 min, respectively) (Figures 1g  and h ). Evoked AMPAR-fEPSPs and paired pulse facilitation were similar between groups (Supplementary Figure 1) . Interestingly, the dentate gyrus of FSL rats showed normal LTP (Supplementary Figure 3) .
Novel object recognition memory in FSL and SD rats
We next investigated hippocampus-dependent memory in FSL rats using the novel object recognition task (NOR) (Figure 2a ) as a test of episodic-like memory. 29 Consistent with the decreased motivational state that is associated with depression, FSL rats spent significantly less time than control rats exploring the objects in a 15 min exploration session (P = 0.01, Mann-Whitney test) (Figure 2b ). We therefore matched the time for object exploration in SD rats to that of FSL rats (see Materials and methods). In a 5-min test session 24 h after the 15-min exploration session, FSL rats showed impaired performance in the NOR task relative to the control SD rats (P = 0.007, Mann-Whitney test) (Figure 2c, right) . We also tested rats' short-term memory using a 5-min test session 1 h after the 5-min exploration session. Again, SD rats spent significantly more time exploring the novel object, whereas FSL rats did not discriminate between the novel and the familiar object and the recognition index between groups were significantly different (P = 0.016, Mann-Whitney test) (Figure 2c, left) .
Reduced D-serine levels in the hippocampi of FSL rats are related to LTP and memory deficits but not to emotional symptoms Because LTP in the CA1 region of the hippocampus is dependent on D-serine, 30 we tested whether we could restore in vitro CA1-LTP in FSL rats by adding a saturating dose of D-serine (100 mM). In FSL rats, in vitro CA1-LTP was restored (to 170 ± 12% of baseline) by the application of D-serine 10 min before HFS (Figures 3a and b) . Interestingly, in SD rats, D-serine had only a minor effect on LTP (Supplementary , which suggests that tissue availability of D-serine is a limiting factor in FSL rats but not in SD rats. Indeed, measuring the D-serine content in hippocampal homogenates from SD and FSL rats using enantioselective chromatography revealed a profound decrease in D-serine levels in FSL relative to SD rats (138.3±7.7 pmol mg À1 of protein vs 189.1± 9.3 pmol mg À1 of protein; P = 0.017, Mann-Whitney test) (Figure 3c) . D-serine application did not affect AMPA receptor evoked glutamatergic transmission in either the FSL or SD rats (Supplementary Figure 4c ) and interestingly when we tested the effect of 100 mM D-serine on the NMDA receptor evoked glutamatergic transmission (measuring the amplitude of evoked fEPSP in the presence of 10 mM DNQX) the increase in NMDAR-fEPSP amplitude was similar between groups (Supplementary Figure 4d) . This result, together with the lack of difference of NMDA receptor fEPSP (Supplementary Figure 1a) suggests both that the functional properties of NMDA receptor in FSL rats are intact and that the activation of the glycinebinding site of the NMDA receptors is not affected in FSL rats. However, when NMDA receptors are extensively stimulated, as during the HFS stimulation to induce LTP, the underperformance due to reduced D-serine levels becomes apparent.
To directly test whether the decrease in D-serine content was responsible for the recognition memory deficit in FSL rats, we injected a single subcutaneous dose of D-serine (600 mg kg À1 ) or saline into adult FSL rats 20 min before the exploration session in the NOR test. After 24 h, in a 5-min test session, the group of D-serine-treated FSL rats spent significantly more time exploring the novel object than the saline-treated FSL group (P = 0.017, unpaired two-tailed Student's t-test) (Figure 3d ), indicating that acute D-serine levels did indeed restore object recognition memory in FSL rats. However, acute D-serine injection did not rescue the exploratory deficit observed in FSL rats (Supplementary Figure 5a) . The lack of effect on emotional symptoms was also confirmed in the forced swim test, which is usually used as an indirect measure of the emotional symptoms of depression. As previously reported 31 we observed a significantly higher immobility time in a single trial version of the forced swim test in FSL compared with SD rats (P < 0.05) (see Materials and methods). This behaviour was not rescued after an acute injection of D-serine (Supplementary Figure 5b) . , During the 15 min of the exploration phase (S1) of the NOR test, the FSL rats spent significantly less time exploring both objects (objects A and B) compared with the control (SD) rats (58.36 ± 2.9 vs 89.45 ± 5.1 s, respectively; *P = 0.01, Mann-Whitney test). Within each group, the rats spent on average the same amount of time exploring each of the two objects (the object A/object B ratio was 0.90 ± 0.06 (SD) vs 0.92 ± 0.08 (FSL). (c) When the rats were allowed equal exploration time in a maximum of 5 or 15-min learning session (S1) the SD rats still recognised the familiar object after 1 or 24 h, respectively, whereas the FSL rats did not. Recognition memory is expressed as the recognition index (RI), which is calculated as ((the exploration time of the novel object (C)-exploration time of the familiar object (A))/(total exploration time (A þ C))) (*P = 0.0159, **P = 0.007, Mann-Whitney; N = 6-9 animals per group). In (b) and (c), the results represent the mean±s.e.m.
It is still possible that long-term changes induced by restoring hippocampal synaptic plasticity and memory with D-serine might be needed to improve the emotional symptoms in depression. Therefore, we chronically treated FSL rats for 3 weeks with daily D-serine (600 mg kg
À1
; subcutaneously) injections and challenged them 24 h after the last injection in the forced swim test. Both saline-treated and D-serinetreated FSL rats were less mobile during a 5-min forced swim test compared with saline-treated SD rats (P = 0.005, one-way ANOVA) (Figure 3e ). FSL rats chronically treated with D-serine still had improved memory as assessed by the NOR (Supplementary  Figure 5c) . Thus, in our model, restoring hippocampal synaptic plasticity by systemically increasing the levels of D-serine did not relieve the emotional symptoms of depression. This finding was accompanied by the observation that 100 mM D-serine did Figure 6) , raising the possibility that increased glutamatergic transmission underlies the depressed pathophysiology in FSL rats.
Reactive astrocytes and decreased GLAST protein expression underlie the increased glutamate transmission in FSL rats Given that the postsynaptic glutamate receptors do not appear to be altered in FSL rats ( Figure 1 ) and that D-serine did not regulate sEPSCs (Supplementary Figure 6) we turned our attention to glutamate reuptake. We blocked the excitatory amino-acid transporters using DL-TBOA, a competitive nontransportable blocker of glutamate transporters in hippocampal slices from SD rats. Relative to baseline, 5 min application of DL-TBOA (50 mM) increased the frequency of sEPSCs by 86.5±16.1% (P = 0.013, paired two-tailed Student's t-test) (Figure 4a ) but did not affect the amplitude or kinetics of these events (Supplementary Table 1 ). Thus, blocking glutamate transporters in SD rats mimicked the increased glutamatergic synaptic activity observed in FSL rats. Consistent with these results, western blot analysis showed decreased hippocampal protein levels of GLAST in FSL rats relative to SD rats (88 ± 3% of SD, P = 0.008, Mann-Whitney test) whereas hippocampal GLT-l protein levels were not significantly different (P = 0.15) (Figure 4b ). The decreased levels of GLAST in FSL rats suggested a deficit in astrocytic function in these rats. This hypothesis was also supported by our finding of decreased levels of D-serine in the hippocampi of these animals (Figure 3c ), as astrocytes are the primary source of D-serine release in the brain. 32 Accordingly, we observed a significant increase in the total protein levels of GFAP in the hippocampi of FSL rats (P = 0.02, Mann-Whitney test) (Figure 4c ). Increased GFAP expression is one of the hallmarks of reactive astrocytes. Other hallmarks include cellular hypertrophy and the stellation and extension of astrocytic processes. 33 We therefore analysed the morphology of the astrocytes in the hippocampus using GFAP immunostaining. In FSL rats the astrocytes localised in the stratum radiatum of CA1 area presented a stellate shape with long processes clearly distinguishable from the more fusiform shape of the astrocytes observed in hippocampal slices from SD animals (Figure 4d) . A quantitative analysis of the cell body size revealed a significant increase in the cell body area in the astrocytes of FSL rats compared with SD rats (188.3 ± 20 vs 82.3 ± 9 mm 2 , respectively; P = 0.008, Mann-Whitney test) (Figure 4d ). In the dentate gyrus, the difference in morphology was less apparent (Figure 3d, Supplementary Figure 7) . Although there was a trend to increase in cell body area in the FSL rats this was not significantly different to SD rats (P = 0.11, Mann-Whitney test) (Supplementary Figure 7 ).
Effect of acute and chronic activation of mGlu2/3 receptors on hippocampal glutamatergic activity in FSL rats Previous studies have shown a reduced expression and function of mGlu2/3 receptors in the hippocampus of FSL rats. 34 As presynaptic activation of mGlu2/3 receptors has been proved to inhibit glutamate release, 35 we tested if the mGlu2/3 receptor agonist, LY354740, could regulate hippocampal glutamatergic transmission in FSL rats. Bath application (15 min) of LY354740 (2 mM) markedly reduced the frequency of sEPSCs but showed no effect on the amplitude of these events (Figures 5a and b) .
We hypothesise that the increased hippocampal glutamatergic activity might be the cause of synaptic plasticity deficit in FSL rats. Therefore, we examined the effect of chronic mGlu2/3 receptor stimulation on FSL CA1-LTP. Adult FSL rats were treated once daily with LY354740 (1 mg kg
; subcutaneously) for 14 days or saline as control treatment. At day 15, in vitro CA1-LTP analysis was performed as above. We observed a significant increase in the potentiation of fEPSP after three HFS in hippocampal slices from LY354740-treated FSL rats compare with saline- .) ) reversed the impaired recognition memory in the FSL rats (*P = 0.017; unpaired two-tailed Student's t-test; N = 5-6 animals per group). (e), Chronic D-serine treatment (for 3 weeks, 600 mg kg À1 ; s.c.) did not increase the mobility of FSL rats in the forced swim test. Relative to control (SD þ saline), the saline-and D-serine-treated FSL rats were significantly less mobile throughout a 5-min forced swim test (***P = 0.005; one-way ANOVA followed by the Bonferroni test; ***P < 0.001; **P < 0.01; n.s., P > 0.05; N = 6-8 animals per group). In (b-e), the results represent the mean ± s.e.m. in panel a, the vertical scale bar represents 0.5 mV, and the horizontal scale bar represents 10 ms. n.s: not significant. treated FSL rats (P < 0.0001, unpaired two-tailed Student's t-test; Figures 5c and d) . These results suggest that reducing excessive glutamate synaptic transmission partially restores synaptic plasticity in our model of depression.
Discussion
Depression is linked to perturbation in glutamatergic neuronal networks within the brain. To date, however, the evidences suggesting this alteration have been based primarily on indirect measurements. Here, we directly show increased glutamatergic synaptic activity in the hippocampal CA1 area of an animal model of depression. We further show that this increase results from reduced expression of the glial glutamate transporter GLAST in combination with reduced presynaptic inhibition through the mGluR2/3 receptor. We also observed morphological and functional changes in astrocytes, which might be the responsible for the lower hippocampal D-serine levels measured in the FSL rat. Moreover, the impaired recognition memory that we observed in the FSL rats can be causally linked to lower D-serine levels and the associated decrease in hippocampal CA1 synaptic plasticity described in FSL rats. The CA1 plasticity deficit in FSL rats has been suggested to be due to reduced levels of glutamate receptors. 24, 26 Although we found a non-significant decrease in the NR1 subunit in the FSL rats (Figure 1) , we did not observe differences in evoked NMDARfEPSP response, either in the absence or presence of high doses of D-serine ( Supplementary Figures 1  and 4 ). This apparent discrepancy could be due to several factors, including the use of SD rats as our reference strain. Previous studies in the FSL model used the flinders resistant line as the reference strain; however, the flinders resistant line strain is a selectively bred strain and therefore differs in some ways from both FSL and SD rats. 36 We therefore chose the SD strain as our control rats, as we wished to study the depression phenotype of the FSL rat relative to a standard laboratory rat rather than the cholinergic sensitivity that was used as the selection criteria during the generation of the FSL and flinders resistant line lines.
Instead of being caused by an alteration in glutamatergic receptors, we suggest that the impaired synaptic plasticity in the FSL rat is the result of a decrease in D-serine levels (Figure 3c ). It is possible that a decrease in D-serine production in FSL rats serves as a safety mechanism to prevent overexcitation of the NMDA receptor. Indeed, increased phosphorylation of the NR1 subunit was recently reported in FSL rats 24 consistent with overexcitation of the NMDA receptor. It has also been shown that genetic deletion of the D-serine synthesising enzyme, serine racemase, protects against cerebral ischaemia and excitotoxicity 37 and that NMDA receptor overactivation inhibits the production of D-serine. 38 This safety mechanism may explain why-despite numerous studies showing pathological glutamate levels in the brain of depressed patients and animal models of depression 10 -no study has reported neuronal death or a decrease in the number of neurons. 39 This mechanism is also consistent with the successful use of NMDA receptor antagonists as antidepressant drugs, including ketamine. 40 In addition to decreased levels of D-serine, we observed a more prominent expression of the astrocytic marker GFAP as well as a significant change in astrocytic morphology specifically in the CA1 area of FSL rats (Figures 4c and d) but not in the dentate gyrus (Supplementary Figure 7) . Increased GFAP is also observed in reactive astrocytes, 41 thus, this finding supports the link between depression and inflammation. 16 It should be noted that reduced levels of GFAP has been reported in the hippocampus and prefrontal cortex of different animal models of depression, [42] [43] [44] but interestingly these studies have also shown increases in S-100b, another marker for reactive astrocytes. These conflicting results highlight the need for further functional studies of astrocytes in depression as well as more clarification of the relationship between the prefrontal cortex and the hippocampus in regulating emotional and cognitive symptoms of depression.
Preclinical and clinical studies have shown decreased expression of GLAST and/or GLT-1 in different brain areas of animal models 45 and depressed patients. 46 Conversely, blocking glial glutamate transporters induce both signs of anhedonia and impaired spatial memory in rats 47 and stimulating these transporters has antidepressant effects in both humans 48 and animal models of depression. 49 Indeed, the antidepressant effect of riluzole is accompanied with an upregulation of hippocampal GLT-1. 44 In our study, we found decreased total hippocampal expression levels of the glia glutamate transporter GLAST in FSL rats (Figure 4b ) and by blocking hippocampal glutamate transporter we faithfully mimicked the increased glutamatergic transmission typical in FSL rats. In spite of this result, the small but significant decrease of GLAST in the hippocampus of FSL rats might not completely explain the abnormal glutamatergic transmission of these animals. Instead, we propose that the decrease in mGlu2/3 receptor expression and function described in FSL rats by others 34 might also be involved. It is easy to envision that a decrease in the inhibitory autoreceptor mGlu2/3 35 expression and function combined with reduced levels of GLAST might cause a synergistic effect on increasing glutamate transmission in our model.
Consistent with the classic view that CA1 synaptic plasticity is related to learning and memory, 21 FSL rats exhibit severely impaired recognition memory in the NOR. Together with the emotional memory impairments that have already been described in FSL rats, 24 this finding reinforces the notion that memory deficits are associated with depression. Interestingly, we found that recognition memory was restored by both acute and chronic systemic administration of D-serine (Figure 3d and Supplementary  Figure 5c ), although this treatment did not have a positive effect on the emotional symptoms of depression (Figure 3e, Supplementary Figure 5b) . These results indicate that restoring hippocampal plasticity through enhancing NMDA receptor activation may not be enough to relieve the emotional aspects of depression. In contrast, enhancing plasticity through blocking NMDA receptors have been shown to underlie the antidepressant effect of ketamine. 50 In this study, we provide another mechanism by which reducing glutamate transmission enhance synaptic plasticity, namely by stimulating mGlu2/3 receptors ( Figure 5 ). Indeed, it has been shown that low doses of the mGlu2/3 receptor agonist, LY379268, combined with a selective serotonin reuptake inhibitor, shorten the latency of the antidepressant effect in the forced swim test. 34 Taken together, these findings underscore the existence of different mechanisms in the regulation of hippocampal plasticity and highlight the importance in understanding their specific contribution in depression.
In summary, our data describe interactions within the glutamatergic system that should be considered when designing new therapies for depression. We suggest that several aspects of glutamatergic regulation should be targeted to effectively treat both the cognitive and emotional symptoms that are associated with depression.
